Articles by Rosie Dawn Griffin

On February 7, 2020, the U.S. Court of Appeals for the Tenth Circuit affirmed summary judgment for the defendant hospital in a False Claims Act (“FCA”) case premised on falsified data.  The case—United States, ex rel. Janssen v. Lawrence Memorial Hosp., 2020 BL 44705 (10th Cir. Feb. 07, 2020)— involved…

The United States Environmental Protection Agency (EPA) has a new Inspector General (IG), following an extended period of oversight by acting IGs.  Sean O’Donnell was confirmed on December 19, 2019 to lead the agency’s Office of Inspector General (OIG), an independent office within the EPA that performs audits, evaluations, and…

Yesterday, Judge Chen of the U.S. District Court for the Northern District of California dismissed claims alleging that Gilead Sciences, Inc. defrauded the United States government and violated the False Claims Act (FCA) by using prohibited ingredients in HIV drugs it sold to government purchasers, including Medicare and Medicaid. The…

Washington, DC – Feldesman Tucker Leifer Fidell LLP (FTLF) is pleased to announce the addition of former U.S. Department of Health and Human Services (HHS), Office of Inspector General (OIG) Senior Counsel Kristen M. Schwendinger and former Department of Justice Honors Program attorney Rosie Dawn Griffin to its False Claims…

We previously reported about a group of False Claims Act (“FCA”) cases brought by the National Healthcare Analysis Group (“NHCA”), a Wall Street funded “professional relator” that has filed nearly a dozen FCA cases advancing a similar legal theory against 38 defendants located throughout the country.  The Department of Justice (“DOJ”)…